For more information or confidential assistance
se habla español

Xarelto Lawsuits Gain Plaintiffs’ Steering Committee

To date, about 100 Xarelto lawsuits filed in federal court systems have been centralized into a multidistrict litigation (MDL), which is proceeding in the U.S. District Court for the Eastern District of Louisiana. Judge Eldon E. Fallon is presiding over the MDL, which was established in December 2014 by the... Read more »

Deceptive Marketing at Crux of Androgel Lawsuit

The U.S. Food and Drug Administration has yet to approve any type of testosterone replacement therapy as a treatment for age-associated low testosterone levels, otherwise known as “Low T.” Yet manufacturers of testosterone supplements have aggressively marketed products like Androgel to thousands of middle aged American men who believed they... Read more »

Xarelto Bleed Victims Join Mass Tort in Philadelphia

Administrative Judge Kevin Dougherty of the Philadelphia Court of Common Pleas recently issued an order that has created a mass tort docket for Xarelto lawsuits filed against Janssen Pharmaceuticals and Bayer Healthcare Pharmaceuticals. The January 21, 2015 order affects at least 75 cases that share common allegations regarding the medication,... Read more »

Microbial Contamination Leads to Xarelto Recall

The Janssen unit of Johnson & Johnson recently announced a Xarelto recall due to the discovery of a microbial contamination. To date, information regarding the exact nature of the contamination has not been released and so far it appears that no patients have suffered an illness because of the problem.... Read more »

Federal Yaz and Yasmin Lawsuits Prepare for Trial

Pharmaceutical giant Bayer has already resolved more than 17,000 Yaz and Yasmin lawsuits involving venous clot injuries, pulmonary embolism and deep vein thrombosis, but hundreds more are still pending in multidistrict litigation No. 2100. While the MDL is still marshalling discovery common to all cases, the presiding Judge, Honorable David... Read more »

Bayer Settles Thousands of Yaz Lawsuits

Bayer Healthcare, a pharmaceutical giant, revealed the resolution of thousands of Yaz lawsuits in its second quarter financial report for 2014. The company and over 17,000 claimants agreed to a settlement of over $1.8 billion. The plaintiffs had sued Bayer with regard to life-threatening side effects that were allegedly caused... Read more »